Hide filtersShow filters × Close Bryan, Garnier & Co announces the successful €18m Private Placement of Nicox Bryan Garnier & Co advises GeNeuro on its Euronext IPO, raising €33 million, acting as Global Coordinator & Joint Bookrunner Capital Raise Florealis Bryan, Garnier & Co announces the successful €25m Placement of Erytech Bryan Garnier & Co advises DBV Technologies on its follow-on offering, raising $281.5m in July 2015, acting as financial advisor Bryan, Garnier & Co announces the successful $100m Nasdaq IPO of Celyad. Bryan, Garnier & Co announces that the total proceeds of Galapagos IPO on Nasdaq, the largest Nasdaq IPO of a European biotech, have been raised to $317m following the full exercise of over-allotment option. Bryan, Garnier & Co announces the successful follow-on offering of £20m for Advanced Oncotherapy plc Bryan, Garnier & Co acts as Placement Agent for Nicox €27m Private Placement (PIPE) Bryan, Garnier & Co acts as Placement Agent for Cardio3 BioScience’s €32m Capital Raise Bryan, Garnier & Co announces the successful IPO of Bone Therapeutics. Bryan, Garnier & Co announces the IPO of Quantum Pharma on London AIM
